Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Amgen, Inc.
Lobbying Relationship
Bills mentioned
H.R.1038: Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007
Sponsor: Jay Inslee (D-Wash.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Richard Molen | Legislative Director for Senator Conrad Burns |
| Pete Leon | Legislative Director for Rep. Eliot Engel |
| Norman Lent | n/a |
| Norman Lent III | n/a |
| Alan Roth | n/a |
| Michael Scrivner | n/a |
| Norman Lent III | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate